Merck KGaA
XETRA:MRK
Merck KGaA
XETRA:MRK
Price:
148.95 EUR
-0.67%
Market Closed
Updated:
May 1, 2024
Merck KGaA
Net Income (Common)
|
Merck KGaA
Net Income (Common) Peer Comparison
Comparables:
ATAI
BAYN
93M1
DMP
PSG
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Merck KGaA
XETRA:MRK
|
Net Income (Common)
€2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
9%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Net Income (Common)
-$40.2m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Net Income (Common)
-€2.9B
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MPH Health Care AG
XETRA:93M1
|
Net Income (Common)
€29.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Net Income (Common)
€62.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Net Income (Common)
€12m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Merck KGaA's Net Income (Common)?
Net Income (Common)
2.8B
EUR
2.8B
EUR
Based on the financial report for Dec 31, 2023, Merck KGaA's Net Income (Common) amounts to 2.8B EUR.
What is Merck KGaA's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
9%
9%
Over the last year, the Net Income (Common) growth was -15%. The average annual Net Income (Common) growth rates for Merck KGaA have been 12% over the past three years , -3% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
